2025 BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party Group Autoimmune Diseases Working Party (ADWP) 1st listed author Raffaella Greco Journal Bone Marrow Transplant.
2025 Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder - recommendations from ECTRIMS and the EBMT Group Autoimmune Diseases Working Party (ADWP) 1st listed author Paolo A Muraro Journal Nat Rev Neurol.
2025 Hematopoietic stem cell transplantation for multiple sclerosis: no inflammation, no response Group Autoimmune Diseases Working Party (ADWP) 1st listed author Richard K Burt Journal Eur J Neurol.
2022 High-dose immunosuppressive therapy with autologous hematopoietic stem cells transplantation for multiple sclerosis: Current view Group Autoimmune Diseases Working Party (ADWP) 1st listed author Alexey Yu. Polushin Journal Cellular Therapy and Transplantation (CTT).
2022 Is stem cell transplantation safe and effective in multiple sclerosis? Group Autoimmune Diseases Working Party (ADWP) 1st listed author Basil Sharrack Journal BMJ.
2022 Immune Reconstitution Following Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: A Review on Behalf of the EBMT Autoimmune Diseases Working Party Group Autoimmune Diseases Working Party (ADWP) 1st listed author Maria Teresa Cencioni Journal Front Immunol.
2020 Rehabilitation Before and After Autologous Haematopoietic Stem Cell Transplantation (AHSCT) for Patients With Multiple Sclerosis (MS): Consensus Guidelines and Recommendations for Best Clinical Practice on Behalf of the Autoimmune Diseases Working Party, Nurses Group, and Patient Advocacy Committee of the European Society for Blood and Marrow Transplantation (EBMT) Group Autoimmune Diseases Working Party (ADWP) Patient Advocacy Committee Nursing Research Committee 1st listed author Fiona Roberts Journal Front Neurol.
2019 Autologous haematopoietic stem cell therapy for multiple sclerosis: a review for supportive care clinicians on behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation. Group Autoimmune Diseases Working Party (ADWP) 1st listed author Ismail A Journal Curr Opin Support Palliat Care.
2019 Evaluating the clinical effectiveness of autologous haematopoietic stem cell transplantation versus disease-modifying therapy in multiple sclerosis using a matching-adjusted indirect comparison: an exploratory study from the Autoimmune Diseases Working Party (ADWP) of the European Society of Bone and Marrow Transplantation (EBMT). Group Autoimmune Diseases Working Party (ADWP) 1st listed author Tappenden P Journal Bone Marrow Transplant.
2019 Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE). Group Autoimmune Diseases Working Party (ADWP) JACIE Working Party 1st listed author Sharrack B Journal Bone Marrow Transplant.
2017 Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis. Group Autoimmune Diseases Working Party (ADWP) 1st listed author Muraro PA Journal Nat Rev Neurol.
2017 Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis. 1st listed author Muraro PA Journal JAMA Neurol.